SCHEMBL10135359

SCHEMBL10135359

Cc1cc(C#N)cc(C2C(=O)Oc3c2cc(C(C)(C)C)cc3C(C)(C)C)c1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 1/20 0.34
GABBR1 Q9UBS5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12901558 0.93 GABBR2 (0.37) GABBR2GABBR1
Water SCHEMBL28204716 0.89 GABBR2 (0.39) GABBR2GABBR1
SCHEMBL5083903 0.88 GABBR2 (0.40) GABBR2GABBR1
SCHEMBL6873135 0.85 KIF11 (0.37) GABBR2GABBR1
SCHEMBL12901560 0.84 GRM2 (0.39) GABBR2GABBR1
Butane SCHEMBL28053792 0.83 GABBR2 (0.37) GABBR2GABBR1
SCHEMBL10135354 0.81 GABBR2 (0.41) GABBR2GABBR1
SCHEMBL5083413 0.81 GABBR2 (0.43) GABBR2GABBR1
SCHEMBL1232621 0.79 GAA (0.42) GABBR2GABBR1
SCHEMBL5083915 0.79 GABBR2 (0.39) GABBR2GABBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859235-B2 Methods in cell cultures, and related inventions, employing certain additives BASF SE (DE) 2014-10-14 US disclosed
US-20120164162-A1 METHODS IN CELL CULTURES, AND RELATED INVENTIONS, EMPLOYING CERTAIN ADDITIVES BASF SE (DE) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120164162-A1 METHODS IN CELL CULTURES, AND RELATED INVENTIONS, EMPLOYING CERTAIN ADDITIVES BBOX1, NEFM, NQO1 GABBR2 497/4885GABBR1 256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.